PerkinElmer
check quantity

BacteriSense 645 Fluorescent Imaging Agent

Near-infrared (NIR) fluorescent agent for in vivo imaging and other applications.  

You successfully added item(s) to your cart

For laboratory use only. This product is intended for animal research only and not for use in humans.

Part Number
List Price
Your Price
Quantity
NEV10080
997.00 USD
more
Buy Now

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Detail Information

BacteriSense™ 645 Targeted Fluorescent Pre-clinical Imaging Agent is a fast-clearing, targeted probe which binds to negatively charged lipids on the bacterial cell membrane, enabling the monitoring of infection progression in vivo non-invasively and in real time. Because the half-life of BacteriSense in vivo is as short as 45 minutes, image data can be acquired every day to track bacterial load during infection. This agent effectively targets infection caused by both gram-negative and gram-positive bacteria.

Specifications

Fluorescent Agent Type Targeted
Optical Imaging Classification Fluorescence Imaging
Product Brand Name BacteriSense
Quantity in a Package Amount 1.0 Units
Shipping Condition Blue Ice
Therapeutic Area Bacterial infection
Unit Size 1 Vial (10 doses)
Wave Length 645 nm
Resources, Events & More
  • All

Brochure

BacteriSense™ 645 (Product Sheet)

Infectious disease research requires the ability to study the progression of infection and effects of treatment in realistic time frames. BacteriSense Fluorescent Pre-clinical Imaging Agent is a fast-clearing, targeted probe which binds to negatively charged lipids on the bacterial cell membrane, enabling the monitoring of infection progression in vivo non-invasively and in real time. Because the half-life of BacteriSense in vivo is as short as 45,minutes, image data can be acquired every day to track bacterial load during infection.

PDF 1 MB

Poster

In vivo imaging and quantification of bacterial infection using a new red fluorescently labeled agent

Bacterial infection is a serious and costly clinical issue, so there is significant need for preclinical tools for assessing infection and therapeutic intervention. Rapid and non-invasive imaging technologies and targeted imaging agents would prove invaluable in diagnosing and managing bacterial infections. To this end, we developed a unique type of fluorescent agent that can quickly target bacteria, providing a fluorescent method to quantify bacterial load during infection as early as one hour post-injection. A red cationic agent (BacteriSenseTM 645) targeting the negative charge at the surface of bacteria was developed

PDF 1 MB

Technical Note

BacteriSense 645 (Data Sheet)

BacteriSense™ 645 is a near-infrared labeled fluorescent in vivo imaging agent that targets Gram positive and Gram negative bacteria.

PDF 213 KB